Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -65.43x is 37% above its 5-year average of -104.08x, near the high end of its 5-year range (-208.73x–-44.53x).
11.87% above its 12-month average of -74.24x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -71.67x.
INTEREST COVERAGE RATIO
-65.43x
INTEREST COVERAGE RATIO AVG TTM
-74.24x
INTEREST COVERAGE RATIO AVG 3Y
-69.29x
INTEREST COVERAGE RATIO AVG 5Y
-104.08x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+11.87%
CURRENT VS 3Y AVG
+5.57%
CURRENT VS 5Y AVG
+37.14%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.22x
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
-951.08%
vs the sector median at left
Disc Medicine, Inc.
Market Cap
$2.41B
Interest Coverage Ratio
-65.43x
TTM Avg
-74.24x
3Y Avg
-69.29x
5Y Avg
-104.08x
Market Cap
$2.41B
Interest Coverage Ratio
N/A
TTM Avg
5.09x
3Y Avg
6.01x
5Y Avg
15.92x
Market Cap
$2.40B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.40B
Interest Coverage Ratio
-78.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.38B
Interest Coverage Ratio
-358.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.35B
Interest Coverage Ratio
26.93x
TTM Avg
18.45x
3Y Avg
12.59x
5Y Avg
12.59x
Market Cap
$2.32B
Interest Coverage Ratio
-2.13x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.31B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.53B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Disc Medicine, Inc. (IRON) | $2.41B | -65.43x | -74.24x | -69.29x | -104.08x |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.41B | N/A | 5.09x | 6.01x | 15.92x |
| Clover Health Investments, Corp. (CLOV)vs › | $2.40B | N/A | N/A | N/A | N/A |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.40B | -78.14x | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.38B | -358.08x | N/A | N/A | N/A |
| ADMA Biologics, Inc. (ADMA)vs › | $2.35B | 26.93x | 18.45x | 12.59x | 12.59x |
| Liquidia Corporation (LQDA)vs › | $2.32B | -2.13x | N/A | N/A | N/A |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.31B | N/A | N/A | N/A | N/A |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.53B | N/A | N/A | N/A | N/A |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.28B | -0.25x | 23.23x | 12.79x | 10.35x |
Interest Coverage
-65.4x
Debt/Equity
0.09
Current Ratio
24.14
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -71.67x |
| 2026-03-31 | -82.37x |
| 2025-12-31 | -75.84x |
| 2025-09-30 | -73.82x |
| 2025-06-30 | -67.48x |
| 2025-03-31 | -44.53x |
| 2021-12-31 | -208.73x |
| 2021-09-30 | -177.40x |
| 2021-06-30 | -134.88x |
| 2021-03-31 | -8.92x |
| 2020-12-31 | 1.58x |
| 2020-09-30 | -3.88x |
| 2020-06-30 | -62.30x |
| 2020-03-31 | -62.95x |
